No Data
No Data
Entourage Announces Results of 2024 Annual General Meeting of Shareholders
ntourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general meeting of shareholders ("AGM") held virtually on June 12, 2024.
Entourage Health Corp: Release Misfire
Earnings Call Summary | ENTOURAGE HEALTH CORP(ETRGF.US) Q1 2024 Earnings Conference
The following is a summary of the Entourage Health Corp. (ETRGF) Q1 2024 Earnings Call Transcript:Financial Performance:Entourage Health Corp. reported a first-quarter revenue of $16.4 million, indica
Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues
TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the fiscal year that ended December 31, 2023.
Entourage Health Provides Corporate Update
Entourage Health Corp. (ENTG.V producer and distributor of cannabis products, on Tuesday announced that Vincent Dore, its Chief Legal Officer and Corporate Secretary, will step down to pursue other ca
Entourage Health Corp (ETRGF) Q3 2023 Earnings Call Transcript
Entourage Health Corp (ETRGF) Q3 2023 Earnings Call Transcript